Trial Profile
Pharmacokinetics and pharmacodynamics of vildagliptin administered immediately or 30 minutes prior to meals in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2012
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 May 2012 New trial record